Twist Bioscience Corporation

Twist Bioscience Corp.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Twist Bioscience Corp. has 62.67M shares outstanding.

As of June 30, 2026, Twist Bioscience Corp. maintains a current ratio of 2.67, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. posted a negative return on equity (ROE) of -29.59, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -20.78, reflecting losses generated across the asset base. The company generates approximately 7.71M in revenue per employee across its workforce of 979.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.79 indicates how many times Twist Bioscience Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. recorded 15.10M in income tax expense. The company reported a pretax loss of -2.37B and -2.39B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. generated 7.54B in revenue and converted that into -2.39B in net income, yielding earnings per share of -38.90. EBITDA reached -2.09B, while operating income came in at -2.41B.

As of June 30, 2026, Twist Bioscience Corp. holds 2.91B in cash and equivalents against 1.64B in total debt, resulting in a net debt position of -2.05B. Total book value stands at 7.79B, with working capital of 3.51B providing operational flexibility.

Twist Bioscience Corp. produced -927.25M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -699.76M in capital expenditures, free cash flow totaled -1.63B - equivalent to -26.50 per share.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. posted a gross margin of 51.97, reflecting its pricing power and cost economics. The operating margin of -31.95 and net profit margin of -31.66 provide insight into operational efficiency.